Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Ovid Therapeutics Inc (OVID)
NASDAQ:OVID
Ovid Therapeutics (OVID) Stock Price & Analysis
1,126 Followers
OVID Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.41 - $3.40
Previous Close$2.62
Volume95.71K
Average Volume (3M)68.52K
Market Cap
$184.69M
Enterprise Value$72.22M
Total Cash (Recent Filing)$129.00M
Total Debt (Recent Filing)$16.54M
Price to Earnings (P/E)-3.4
Beta0.63
Next Earnings
May 09, 2023EPS Estimate
-$0.17Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.77
Shares Outstanding70,491,510
10 Day Avg. Volume58,806
30 Day Avg. Volume68,521
Standard Deviation0.26
R-Squared0.05
Alpha0.00803
Financial Highlights & Ratios
Price to Book (P/B)1.40
Price to Sales (P/S)122.90
Price to Cash Flow (P/CF)1.30
P/FCF Ratio-3.10
Enterprise Value/Market CapN/A
Enterprise Value/Revenue48.06
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-1.33
Forecast
1Y Price Target
$4.75Price Target Upside81.30% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Ovid Therapeutics News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
OVID FAQ
What was Ovid Therapeutics Inc’s price range in the past 12 months?
Ovid Therapeutics Inc lowest stock price was $1.41 and its highest was $3.40 in the past 12 months.
What is Ovid Therapeutics Inc’s market cap?
Currently, no data Available
When is Ovid Therapeutics Inc’s upcoming earnings report date?
Ovid Therapeutics Inc’s upcoming earnings report date is May 09, 2023 which is in 43 days.
How were Ovid Therapeutics Inc’s earnings last quarter?
Ovid Therapeutics Inc released its earnings results on Mar 13, 2023. The company reported -$0.16 earnings per share for the quarter, beating the consensus estimate of -$0.172 by $0.012.
Is Ovid Therapeutics Inc overvalued?
According to Wall Street analysts Ovid Therapeutics Inc’s price is currently Undervalued.
Does Ovid Therapeutics Inc pay dividends?
Ovid Therapeutics Inc does not currently pay dividends.
What is Ovid Therapeutics Inc’s EPS estimate?
Ovid Therapeutics Inc’s EPS estimate is -$0.17.
How many shares outstanding does Ovid Therapeutics Inc have?
Ovid Therapeutics Inc has 70,491,510 shares outstanding.
What happened to Ovid Therapeutics Inc’s price movement after its last earnings report?
Ovid Therapeutics Inc reported an EPS of -$0.16 in its last earnings report, beating expectations of -$0.172. Following the earnings report the stock price went up 0.5%.
Which hedge fund is a major shareholder of Ovid Therapeutics Inc?
Among the largest hedge funds holding Ovid Therapeutics Inc’s share is Driehaus Capital Management LLC. It holds Ovid Therapeutics Inc’s shares valued at 3M.
---
Ovid Therapeutics Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$4.75 (81.30% Upside)
$4.75 (81.30% Upside)
Blogger Sentiment
Bullish
OVID Sentiment 100%
Sector Average 68%
Sector Average 68%
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.9%
Last 30 Days ▼ 2.5%
Last 30 Days ▼ 2.5%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-16.56%
12-Months-Change
Fundamentals
Return on Equity
-34.72%
Trailing 12-Months
Asset Growth
-20.19%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Ovid Therapeutics Inc
Ovid Therapeutics, Inc. focuses on developing medicines for patients and families living with rare neurological disorders. The company was founded by Matthew During in April 2014 and is headquartered in New York, NY.
---
Top 5 ETFs holding OVID
Currently, no data available
Please return soon. This page is being updated.
Up to five ETFs with an Outperform Smart Score that hold OVID. The ETFs are listed according to market value of OVID within the ETF
---
---